Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WXSH0102 tablets in vulvovaginal candidiasis (phase II)
CTR20244891Phase 2Completed
- Sponsor
- Cisen Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WXSH0102 in vulvovaginal candidiasis (VVC), sponsored by Cisen Pharmaceutical Co., Ltd.. Started Dec 2024; status: completed.
02
Drugs
WXSH0102
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on CTR20244891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244891.